SEC Company Response from CytoDyn Inc. (CYDY) (CIK 0001175680) (CYDY) — Oct 19, 2016
CytoDyn Inc. (CYDY) (CIK 0001175680)
Date: Oct. 19, 2016 · CIK: 0001175680 · Accession: 0001193125-16-741835
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-213866
Letter
Acceleration Request
CytoDyn Inc.
1111 Main Street, Suite 660
Vancouver, Washington 98660
October 19, 2016
VIA EDGAR SUBMISSION
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Re: REQUEST FOR ACCELERATION OF EFFECTIVENESS
CytoDyn Inc.
Registration Statement on Form S-3
File No. 333-213866
Ladies and Gentlemen:
CytoDyn Inc. (the “Company”) hereby respectfully requests the acceleration of the effectiveness of the above-referenced Registration Statement (the “Registration Statement”) so that the Registration Statement will become effective at 9:00 a.m. (Eastern time) on Friday, October 21, 2016, or as soon thereafter as practicable.
Please provide a copy of the Commission’s order declaring the Registration Statement effective to Steven M. Skolnick of Lowenstein Sandler LLP, counsel to the Company, at (646) 414-6947, as soon as the Registration Statement has been declared effective.
Very truly yours,
CytoDyn Inc.
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver, Washington 98660 October 19, 2016 VIA EDGAR SUBMISSION United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Re: REQUEST FOR ACCELERATION OF EFFECTIVENESS CytoDyn Inc. Registration Statement on Form S-3 File No. 333-213866 Ladies and Gentlemen: CytoDyn Inc. (the “Company”) hereby respectfully requests the acceleration of the effectiveness of the above-referenced Registration Statement (the “Registration Statement”) so that the Registration Statement will become effective at 9:00 a.m. (Eastern time) on Friday, October 21, 2016, or as soon thereafter as practicable. Please provide a copy of the Commission’s order declaring the Registration Statement effective to Steven M. Skolnick of Lowenstein Sandler LLP, counsel to the Company, at (646) 414-6947, as soon as the Registration Statement has been declared effective. Very truly yours, CytoDyn Inc. /s/ Michael D. Mulholland Michael D. Mulholland Chief Financial Officer